Canopy Growth Corporation - stock earnings
CGC Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -163.5 million USD | 59.2 million USD |
| 2023Q3 | -228.1 million USD | 60.4 million USD |
| 2023Q2 | -28.8 million USD | 82.1 million USD |
| 2023Q1 | -478.7 million USD | 64.7 million USD |
| 2022Q4 | -196.7 million USD | 74.6 million USD |
| 2022Q3 | -169.2 million USD | 86.0 million USD |
| 2022Q2 | -1.6 billion USD | 85.4 million USD |
| 2022Q1 | -462.2 million USD | 89.3 million USD |
| 2021Q4 | -91.4 million USD | 111.5 million USD |
| 2021Q3 | -8.7 million USD | 103.6 million USD |
| 2021Q2 | 316.6 million USD | 109.9 million USD |
| 2021Q1 | -557.3 million USD | 118.2 million USD |
| 2020Q4 | -710.4 million USD | 119.8 million USD |
| 2020Q3 | -24.1 million USD | 101.6 million USD |
| 2020Q2 | -79.9 million USD | 81.3 million USD |
| 2020Q1 | 322.3 million USD | 76.1 million USD |
| 2019Q4 | -92.6 million USD | 94.8 million USD |
| 2019Q3 | -973.3 million USD | 68.6 million USD |
| 2019Q2 | -980.0 million USD | 69.1 million USD |
| 2019Q1 | -249.9 million USD | 70.0 million USD |
| 2018Q4 | 49.6 million USD | 61.0 million USD |
| 2018Q3 | -61.6 million USD | 19.9 million USD |
| 2018Q2 | -60.6 million USD | 19.6 million USD |
| 2018Q1 | -47.8 million USD | 17.7 million USD |
| 2017Q4 | 1.3 million USD | 17.3 million USD |
| 2017Q3 | -3.5 million USD | 12.8 million USD |
| 2017Q2 | -3.3 million USD | 12.2 million USD |
| 2017Q1 | -15.8 million USD | 11.0 million USD |
| 2016Q4 | 2.2 million USD | 7.3 million USD |
| 2016Q3 | -3.0 million USD | 5.3 million USD |
| 2016Q2 | -3.1 million USD | 5.4 million USD |
| 2016Q1 | -3.9 million USD | 3.9 million USD |
| 2015Q4 | -2.4 million USD | 2.5 million USD |
| 2015Q3 | 754114 USD | 1.3 million USD |
| 2015Q2 | 815691 USD | 1.4 million USD |
| 2015Q1 | -1.0 million USD | 592521 USD |
| 2014Q4 | -2.3 million USD | 552692 USD |
| 2014Q3 | -1.0 million USD | 169132 USD |
| 2014Q2 | -1.1 million USD | 176983 USD |
| 2014Q1 | -2.5 million USD | 580445 USD |
| 2013Q4 | -35481 USD | 937 USD |
| 2013Q3 | -7050 USD | 966 USD |
| 2013Q2 | -26921 USD | 45 USD |
| 2013Q1 | -4841 USD | 949 USD |
| 2012Q4 | -2461 USD | 1007 USD |
| 2012Q3 | -21306 USD | ? USD |
| 2012Q2 | -11541 USD | 969 USD |
| 2012Q1 | -7582 USD | ? USD |
| 2011Q4 | -369 USD | 1222 USD |
| 2011Q3 | -2321 USD | 1202 USD |
| 2011Q2 | -9288 USD | 1225 USD |
| 2011Q1 | -7769 USD | 1242 USD |
| 2010Q4 | -138 USD | 549 USD |
| 2010Q3 | -2810 USD | ? USD |
| 2010Q2 | -12467 USD | 1398 USD |
| 2010Q1 | -8644 USD | ? USD |
| 2009Q4 | -17147 USD | ? USD |
CGC Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -2.4 billion USD | 297.8 million USD |
| 2022 | -256.0 million USD | 415.7 million USD |
| 2021 | -1.3 billion USD | 435.2 million USD |
| 2020 | -978.6 million USD | 281.3 million USD |
| 2019 | -499.0 million USD | 168.5 million USD |
| 2018 | -42.0 million USD | 60.5 million USD |
| 2017 | -12.5 million USD | 29.9 million USD |
| 2016 | -2.7 million USD | 9.8 million USD |
| 2015 | -7.0 million USD | 904140 USD |
| 2014 | -844385 USD | 987354 USD |
| 2013 | -63600 USD | 4079 USD |
| 2012 | -21473 USD | ? USD |
| 2011 | -24773 USD | 4619 USD |
| 2010 | -26511 USD | 540 USD |
CGC
Price: $10.23
52 week price:
Earnings Per Share: -15.56 USD
P/E Ratio: -0.27
Exchange: NMS
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 11.1 million
Market Capitalization: 712.2 million